Clinical Trial Update: Risk of Reactivation of Occult Hepatitis B in Cancer Patients During Immunotherapy.

View source ↗

Summary

A clinical trial update warns of the risk of occult hepatitis B reactivation in cancer patients receiving immunotherapy, highlighting concerns about HBV in this…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Occult Hepatitis Infection

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Occult Hepatitis B Infection in Cancer Patients | Status: ACTIVE_NOT_RECRUITING